Literature DB >> 12521585

Antimicrobial therapy for bacterial and nonbacterial prostatitis.

Jackson E Fowler1.   

Abstract

Antimicrobial therapy is the standard of care for the unusual man with true chronic bacterial prostatitis but does not have much of a role in the treatment of men with nonbacterial prostatitis. The fluoroquinolone antibiotics given for 2 to 4 weeks will cure about 70% of chronic bacterial infections of the prostate. If this treatment fails, the symptomatic manifestations of the infections can almost always be eliminated with suppressive antimicrobial therapy using trimethoprim-sulfamethoxazole, a fluoroquinolone antibiotic, or nitrofurantoin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12521585     DOI: 10.1016/s0090-4295(02)02300-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.

Authors:  Tommaso Cai; Sandra Mazzoli; Francesca Meacci; Vieri Boddi; Nicola Mondaini; Gianni Malossini; Riccardo Bartoletti
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

2.  Effectiveness and safety of nitrofurantoin in outpatient male veterans.

Authors:  Michelle L Ingalsbe; Amy L Wojciechowski; Kelly A Smith; Kari A Mergenhagen
Journal:  Ther Adv Urol       Date:  2015-08

3.  Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome.

Authors:  Benjamin Kulovac; Damir Aganović; Alden Prcić; Osman Hadziosmanović
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

4.  Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis.

Authors:  Yumi Seo; Gilho Lee
Journal:  Korean J Urol       Date:  2013-07-15

5.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.